A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's disease is described in Nature Medicine. This protein signature may improve the ...

A new report explains how a woman with signs of Alzheimer's disease in her brain had no symptoms. Here's what her story can ...

The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring ...

biomarkers. Sample selection is critical and should rely on antemortem tissue from subjects that have postmortem confirmation of AD. Cerebrospinal fluid (CSF) is often used for AD studies because ...

Genentech announced that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s ...

AC Immune (ACIU) announced additional interim safety and positive immunogenicity data from the Phase 2 VacSYn clinical trial evaluating ...

Roche Holdings AG (OTC:RHHBY) on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and ...

Current biomarkers of cognitive impairment in individuals with Alzheimer’s disease perform poorly. Now, a stronger predictor ...